Nephros (NEPH) Cash from Financing Activities (2010 - 2026)
Nephros (NEPH) recorded quarterly Cash from Financing Activities of $289000.0 in Q1 2026, up 29000.0% quarter-over-quarter from -$1000.0 in Q4 2025, and up 29000.0% on a YoY basis from N/an in Q1 2025.
Nephros (NEPH) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Nephros' Cash from Financing Activities history runs 17 years deep, the most recent figure standing at $289000.0 for Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 29000.0% year-over-year to $289000.0; the TTM figure through Mar 2026 stood at $285000.0 (up 7225.0% YoY), while the FY2025 annual figure was -$5000.0, changed 0.0% from the prior year.
- Cash from Financing Activities was $289000.0 for Q1 2026 at Nephros, up from -$1000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $289000.0 in Q1 2026 to a low of -$111000.0 in Q4 2022.
- Historically, Cash from Financing Activities has averaged $15600.0 across 5 years, with a median of -$2000.0 in 2023.
- The sharpest annual moves came in 2022 and 2026: Cash from Financing Activities slumped 250.0% in 2022, then surged 29000.0% in 2026.
- A 5-year view of Cash from Financing Activities shows it stood at -$111000.0 in 2022, then jumped by 97.3% to -$3000.0 in 2023, then jumped by 66.67% to -$1000.0 in 2024, then changed by 0.0% to -$1000.0 in 2025, then soared by 29000.0% to $289000.0 in 2026.
- The last three Cash from Financing Activities figures came in at $289000.0 (Q1 2026), -$1000.0 (Q4 2025), and -$2000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -1.35 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -414.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -13.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -255.24 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -308.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -50.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -48.13 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -11.00 Mn |
| 10 | Nephros | 34.19 Mn | 30.17 Mn | 2.99 Mn | 289,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 289,000.00 |
| Mar 31, 2026 | 289,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Sep 30, 2025 | -2,000.00 |
| Sep 30, 2025 | -2,000.00 |
| Jun 30, 2025 | -1,000.00 |
| Jun 30, 2025 | -1,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Dec 31, 2023 | -3,000.00 |
| Dec 31, 2023 | -3,000.00 |
| Jun 30, 2023 | -2,000.00 |
| Jun 30, 2023 | -2,000.00 |